Micafungin Salvage Mono-therapy in Invasive Aspergillosis

Stopped Study was stopped due to difficulties in recruitment and changes in standard care for invasive aspergillosis

Conditions

• Invasive Aspergillosis

Interventions

• DRUG: Micafungin
• DRUG: Systemic antifungal therapy

Sponsor

Astellas Pharma Inc